News and Announcements
YPB Wins Four Year Contract with Mexican National Lottery with an Estimated Value of A$5.6m
- Published July 10, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
YPB Group (ASX:YPB), a pioneering advanced brand protection solutions company, is pleased to announce that its JV with Affyrmx LLC has been selected by Loteria Nacional Para La Assistencia Publica, Mexico’s National Lottery Office, to supply its register of winning tickets.
KEY TAKEAWAYS:
- The contract with Affyrmx JV in Mexico is a four year agreement supply contract with an estimated value of A$5.6m over term with revenues of A$1.4m per annum.
- Four print runs per week to supply winning ticket registers with specialised security features.
- This has been named the most significant contract win to date in Mexico.
YPB Executive Chairman John Houston said:
“This is the most significant contract we have won in Mexico. The contract win demonstrates the strength of our JV’s relationships in Mexico and our ability to package technology solutions to supply high quality and competitively priced Vital Government Documents. We are honoured to have been selected by Loteria Nacional Para La Assistencia Publica and look forwards to a long and mutually beneficial relationships.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
